Loading clinical trials...

RECRUITINGNA

Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes

NCT06542627•Kangbuk Samsung Hospital

Summary

This study aimed to evaluate the effectiveness of use of Continuous Glucose Monitoring (CGM), combined with personalized dietary education and use of smartphone applications in improving glucose control and weight management.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects over the age of 19
•Patients with type 2 diabetes
•* Fasting blood glucose ≥ 126 mg/dL or
•* HbA1c ≥ 6.5% or
•* Type 2 diabetes by clinical history and treated with antidiabetic medications or lifestyle Modifications
•Patients with prediabetes
•* Fasting blood glucose 100-125 mg/dL
•* HbA1c 5.7-6.4%
•Willing to participate in the study

Exclusion Criteria

•Subjects less than 19 years old
•Patients with type 1 diabetes
•Pregnant at the time of screening or planning to become pregnant during the study
•Severe chronic diseases such as cancer, stroke, proliferative retinopathy, myocardial infarction, chronic renal disease, or amputation of a diabetic foot
•Diagnosed with or treated for myocardial infarction, stroke, end-stage renal disease, liver failure, or chronic lung disease within the past year
•Severe liver disease (e.g., cancer, liver cirrhosis, hepatitis B, hepatitis C)
•Diseases of the biliary tract, thyroid disorders, autoimmune disorders, or acute infections
•Planning to be admitted to a hospital within 2 months
•Unable to participate in the mobile intervention study as determined by the investigator

Locations (1)

Kangbuk Samsung Hospital

Seoul, South Korea

Key Dates

Start Date

May 22, 2023

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2025

Last Updated

August 7, 2024

Enrollment

420

ESTIMATED participants

Conditions

PreDiabetesDiabetes Mellitus, Type 2

Interventions

Freestyle Libre

DEVICE

Contacts

Park

CONTACT

0220011550 cydoctor68@gmail.com

CONTACT

0220011550 sjaks999@gmail.com

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

NCT05119179

PreDiabetes

View study

RECRUITINGNA

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901

Obesity and Diabetes Mellitus, Type 2Diabetes Prevention

View study

RECRUITINGNA

Rural Alliance for Diabetes Prevention

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 7, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Inclusion Criteria

Exclusion Criteria

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Rural Alliance for Diabetes Prevention

WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time

Human Immunodeficiency Virus (HIV) Food Insecurities

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion